Search
Close this search box.

Day: August 24, 2021

GenScript Biotech Reports First Half 2021 Results

Posts explosive growth in GCT CDMO business and strategic GCT investments NANJING, China, Aug. 24, 2021 /PRNewswire/ — GenScript Biotech Corporation (HKEX: 1548.HK) (GenScript) today reported its first half 2021 financial results for the six months ended June 30. It also announced that the Group has expanded its presence in the gene and cell therapy (GCT) industry with aggressive […]

Read More . .

Dante Labs Announces Appointment of Mark Van Oene to its Board of Directors to Support Operational Approach and Commercial Strategy

CAMBRIDGE, United Kingdom, Aug. 24, 2021 (GLOBE NEWSWIRE) — Dante Labs, a global leader in genomics and precision medicine, announced today the appointment of Mark Van Oene as a member of its Board of Directors. Mark is the Chief Operating Officer at Pacific Biosciences, a leading provider of high-quality sequencing solutions. “I’m so pleased to […]

Read More . .

Conagen Expands Natural Preservation by Fermentation

Bedford, Mass., Aug. 24, 2021 (GLOBE NEWSWIRE) — As the “clean label” trend thrives in many consumer product categories, Massachusetts-based biotech Conagen announced the launch of a natural preservative, p-Coumaric Acid (PCA). Conagen’s PCA is made by fermentation and expands the natural preservatives offered by its commercialization partner Blue California. The natural preservation market is […]

Read More . .

Lakemore Partners Closes Its US$400 Million Aquatine IV Fund

LONDON, DUBAI, UAE and Scottsdale, Ariz., Aug. 24, 2021 /PRNewswire/ — Lakemore Partners Ltd. and its group entities (“Lakemore”), a leading private credit investment firm primarily investing in control CLO equity, today announced it has successfully closed Aquatine IV at US$400 million as a result of strong investor demand. Aquatine IV is Lakemore’s fourth CLO fund within […]

Read More . .